Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hideto Ochiai is active.

Publication


Featured researches published by Hideto Ochiai.


Transplantation | 1997

Alteration of reticuloendothelial phagocytic function and tumor necrosis factor-α production after total hepatic ischemia

Shohachi Suzuki; Satoshi Nakamura; Takanori Sakaguchi; Hideto Ochiai; Hiroyuki Konno; Satoshi Baba; Shozo Baba

BACKGROUND This study was conducted to determine whether the duration of total hepatic ischemia influences reticuloendothelial phagocytic activity and tumor necrosis factor (TNF)-alpha production after reperfusion. METHODS Male rats pretreated with either normal saline (NS group) or gadolinium chloride (7 mg/kg) for 2 days to inhibit Kupffer cell function (GC group) were subjected to 30, 60, or 90 min of total hepatic ischemia. RESULTS The animals tolerated hepatic ischemia well for 30 and 60 min. Although the 7-day survival rate of the NS group decreased to 28% after 90 min of hepatic ischemia, that of the GC group improved significantly to 68% (P<0.01). In the NS group, plasma alanine transaminase and TNF-alpha levels after reperfusion increased with the length of hepatic ischemia. The phagocytic index (PI) after 60 min of reperfusion following 90 min of hepatic ischemia showed significant depression compared with the preischemic level and the value after 30 or 60 min of ischemia. The GC group had significantly lower plasma alanine transaminase and TNF-alpha levels as well as significantly less polymorphonuclear leukocyte infiltration in the liver compared with the NS group. The preischemic PI was significantly inhibited in the GC group when compared with that in the NS group, but PI in the GC group did not change significantly after reperfusion, irrespective of the ischemic time. CONCLUSIONS This study demonstrated that warm ischemia of up to 60 min is tolerable for normal rat liver without a detrimental effect on phagocytic activity. Modulation of Kupffer cell function may have the potential to prevent reperfusion injury after hepatic ischemia, which may allow safe prolongation of the ischemic time.


Surgery Today | 1999

Double cancer of the gallbladder and common bile duct associated with an anomalous pancreaticobiliary ductal junction without a choledochal cyst: report of a case.

Shohachi Suzuki; Satoshi Nakamura; Hideto Ochiai; Satoshi Baba; Takanori Sakaguchi; Yasuo Tsuchiya; Yoshimitsu Kojima; Hiroyuki Konno

We report herein the case of a 37-year-old woman found to have double cancer of the gallbladder and common bile duct associated with an anomalous pancreaticobiliary ductal junction (APBDJ) without a choledochal cyst (CC). Abdominal ultrasonography showed an isoechoic mass in the gallbladder, and percutaneous transhepatic biliary drainage tubography revealed incomplete obstruction in the upper portion of the common bile duct and APBDJ. The patient underwent cholecystectomy, partial hepatic resection, pancreatoduodenectomy, and portal vein reconstruction. Pathological examination of the tumors from the gallbladder and bile duct revealed papillary carcinoma and poorly differentiated adenocarcinoma, respectively, and direct continuity was not observed between the tumors. A review of the literature on six cases of multiple primary carcinoma of the biliary tract associated with APBDJ without CC is presented following this case report. Double cancer of the biliary tract was found synchronously in five patients and metachronously in one. Gallbladder cancer showed subserosal invasion in four patients, while bile duct cancer invaded the pancreas in one patient and reached the serosa in two patients. Considering the potential for cancer to arise in the biliary tract and the difficulties associated with monitoring it, cholecystectomy and resection of the extrahepatic common bile duct may be the most appropriate treatment for patients with an APBDJ without a CC.


Surgery Today | 1998

Primary Dissection of the Hepatic Artery : Report of a Case

Satoshi Nakamura; Shohachi Suzuki; Takashi Hachiya; Hideto Ochiai; Hiroyuki Konno; Shozo Baba; Satoshi Baba

Dissecting aneurysms of the hepatic artery are extremely rare. We report herein the case of a 51-year-old man with massive hepatic metastases from rectal carcinoma, who was found incidentally to have a left hepatic artery aneurysm by a preoperative angiography. After replacing the left hepatic artery with a 2-cm segment of long saphenous vein, an extended right lobectomy with partial resection of the left lateral segment for multiple metastases was successfully performed. To prevent thrombus formation at the anastomosis, the Pringle maneuver was not used during dissection of the hepatic parenchyma. Histological examination of the resected specimen showed a dissecting aneurysm of the left hepatic artery, but there were no findings to suggest the etiology of this disease. The patient is currently alive 13 months after his operation without any evidence of further recurrence of the carcinoma. To the best our knowledge, 12 case reports of this anomaly have been documented, but only one of these describes a successful operation. The clinical features and etiology of the hepatic artery aneurysm that develops independent of other vascular diseases are discussed following this case report.


American Journal of Surgery | 1997

Direct hepatic vein anastomosis during hepatectomy for colorectal liver metastases

Satoshi Nakamura; Shohachi Suzuki; Takashi Hachiya; Hideto Ochiai; Hiroyuki Konno; Shozo Baba

BACKGROUND When the right and middle hepatic veins (RHV and MHV) and all the short hepatic veins are removed during resection of segments (S) 7 and 8 and part of S 5 and 6 including the caudate lobe, the remainder of S 5 and 6 shows congestion, so restoration of liver function may be delayed. METHODS In 5 patients with hepatic metastases of colorectal carcinoma, which were in the region circumscribed by the RHV, MHV, and inferior vena cava, direct hepatic vein anastomosis was performed during hepatectomy. RESULTS Hepatic vein reconstruction took 17 to 30 minutes to complete. All 5 patients had an uneventful postoperative course, and the anastomosis was patent at 1 month after operation. One patient died of recurrent carcinoma 6 months after operation. Four have remained alive and disease free for 12, 24, 40, and 61 months. CONCLUSION Direct hepatic vein anastomosis is an option, which should be adopted in hepatectomy, especially in patients with carcinoma invading the major hepatic veins and short hepatic veins.


Surgery Today | 2003

Groin infection caused by a percutaneous femoral artery closure device: report of a case.

Naoto Yamamoto; Kenichi Koyano; Masaki Azuma; Hideto Ochiai; Takashi Kashiwabara

Hemostasis after femoral artery catheterization is generally achieved by manual compression, which results in a low incidence of infection at the puncture site. Percutaneous femoral artery closure devices have recently been used to prevent bleeding complications, shorten the hospital stay, and reduce the patients discomfort. However, they have been associated with infectious complications, necessitating surgical intervention, such as patch angioplasty or arterial bypass; the treatment depending on the damage to the artery and the type of device used. Thus, the possibility of infection should be kept in mind when employing these devices. We report a case of groin infection associated with one such device, known as “The Closer,” which was successfully treated by drainage and removal of the suture material.


Journal of Hepato-biliary-pancreatic Surgery | 1997

Surgical management of recurrence after resection of colorectal liver metastases

Shohachi Suzuki; Satoshi Nakamura; Hideto Ochiai; Hiroyuki Konno; Shozo Baba; Satoshi Baba; Kenzo Yasui

The optimal treatment for recurrent lesions after hepatectomy for colorectal liver metastases is controversial. We report the outcome of aggressive surgery for recurrent disease after the initial hepatectomy and the influence on quality of life of such treatment. Forty-five (70%) of the 64 surviving patients developed recurrence after the initial hepatectomy for liver metastases. The determinants of hepatic recurrence were the distribution and the number of liver metastases. Twenty-eight (62%) of patients with recurrence underwent resection. A second hepatectomy was performed in 20 patients, and a third hepatectomy was done in 5 patients. Ten patients with pulmonary metastasis underwent partial lung resection on 14 occasions, while resection of brain metastases was performed in 3 patients on 5 occasions. There were no operative deaths after resection of recurrent disease. The morbidity rate was 28% after repeat hepatectomy, 21% after pulmonary resection, and 0% after resection of brain metastasis. The Karnofsky performance status (PS) after the last surgery was not significantly different from that after the initial hepatectomy. The 3- and 5-year survival rates after the second hepatectomy were 54% and 14%, respectively. The 3-and 5-year survival rates of the patients undergoing resection of extrahepatic recurrence were both 17%. The survival rate after resection of recurrent disease (n=28) was significantly better than that of patients (n=17) with unresectable recurrence (P < 0.05). For the 66 patients with colorectal liver metastases, the 5-year survival rate after initial hepatectomy was 50%. The distribution and the number of liver metastases and the presence of extrahepatic disease, as single factors, significantly affected prognosis after the initial hepatectomy. Multivariate analysis revealed that only the presence of extrahepatic metastasis and a disease-free interval of less than 6 months were independent predictors of survival after the initial and second hepatectomy, respectively. It is concluded that aggressive surgery is an effective strategy for selected patients with recurrence after initial hepatectomy. Careful selection of candidates for repeat surgery will yield increased clinical benefit, including long-term survival.


Case reports in pathology | 2014

A Rare Collision Tumor Composed of Follicular Lymphoma and Adenocarcinoma in the Ampulla of Vater: A Case Report

Shioto Suzuki; Fumihiko Tanioka; Keisuke Inaba; Shingo Takatori; Hideto Ochiai; Shohachi Suzuki

The duodenum is infrequently affected by malignant lymphoma, and follicular lymphomas of the duodenum are rare histological subtypes. There are no reported cases of collision of follicular lymphoma and other tumors in the ampulla of Vater. A 57-year-old Japanese man presented with jaundice, and abdominal computed tomography revealed a tumor of the ampulla of Vater invading the pancreatic head with biliary dilatation and a thickened duodenal wall. The patient underwent subtotal stomach-preserving pancreaticoduodenectomy. Histopathology of the resected specimen revealed lymphoid follicular formations with small-to-medium-sized centrocyte-like cells and some centroblast-like cells. The atypical lymphoid cells were immunohistochemically positive for CD10, CD20, and CD79a but negative for CD5 and cyclin D1. BCL2 protein was highly expressed in the follicle centers. The diagnosis was duodenal follicular lymphoma, Grade 1. The follicular lymphoma, 40 mm in diameter, involved duodenal submucosa and regional lymph nodes without distant metastasis. This duodenal follicular lymphoma was partially overlapped by adenocarcinoma of the ampulla of Vater, measuring 25 × 20 mm, which involved the lower common bile duct, pancreas, and duodenum. We report the first case of a surgically treated collision tumor composed of a rare mass-forming follicular lymphoma and adenocarcinoma of the ampulla of Vater.


Cancer Research | 2015

Abstract 4619: DNA adductome analyses at multiple sites of human gastric mucosa, resected for gastric cancer

Nobuya Kurabe; Ippei Ohnishi; Masako Suzuki; Yusuke Inoue; Tomoaki Kahyo; Moriya Iwaizumi; Yoshitaka Matsushima; Yukari Totsuka; Hitoshi Nakagama; Masako Kasami; Hideto Ochiai; Keigo Matsumoto; Shioto Suzuki; Fumihiko Tanioka; Haruhiko Sugimura

Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA DNA adducts are recognized as an initiative step of mutagenesis, but the measurement of them is still a technical challenge. So-called adductome approach, based on LC-MS/MS, is a popular procedure to identify multiple DNA adducts in various tissues at a single experiments. Recently we reported 7 lipid peroxidation-induced DNA adducts in human gastric mucosa resected for gastric cancer in two countries for the first time, and showed the profile of these DNA adducts could indicate geo-pathological background of gastric mucosa (Matsuda 2013). Though DNA adductome approach posesses the high throghput potential in terms of finding numerous specis of DNA adducts having different molecular weights, there are still challenges to overcome. First of all, the numbers of the standards of DNA adducts molecules available are less than the species with identified molecular weight. This implies there are much more DNA modifications in human tissues than previously characterized. The other challaenge is that the absolute quantifications of these adducts requires isotopic standard chemicals. In this study, we strengthened DNA adductome method by including as many as known adducts in the assay system. Mass/Charge value and liquid chromatography retention time of known 254 DNA addcuts were collected and incoporated into LC-MS/MS machine (4000-QTRAP; Thermo). By this procedure we could measure the 254 DNA adducts at one time in MRM mode. Using this system, we measured 254 DNA adducts in the following human gastric mucosa. Written informed consents were obtained from the patients who took gastrectomy for gastric cancer. Under the hypothesis of field cancerization of gastric mucosa, in order to analyze the spatial influence of the exposure of the potential carcinogens toward cancer site, muocsal tissue at multiple sites with different distance to cancer, (10cm and more distant from the tumor site in the stomach to the site adjacent to the tumor) were taken. Three to 10 sites/case were investigated for DNA adducts measurements. Totally 11 cases and 77 sites are analyzed. Considerable numbers of known DNA adducts were present in human gastric mucosa in different quantities. Among them, tobacco-related and lipid-peroxidation-induced DNA adducts were noted. We also did the same measurements in proximal, middle, and distal gastric mucosa from autospy cases without gastric cancer and compared them to those of the cancer cases. Among them, etheno-dA was able to be quantitatively measured using isotopic standard. The mean level of etheno dA in the gastric mucosa of autopsy cases without gastric cancer was 8.02/107 nucleotides, while that of gastric cancer patients mucosae was 4.80/107 nucleotides. These comprehensive identifications in adducts in human gastric mucosa will provide the basic information for dosimetry and risk assessment of environmental chemicals toward gastric cancer. Citation Format: Nobuya Kurabe, Ippei Ohnishi, Masako Suzuki, Yusuke Inoue, Tomoaki Kahyo, Moriya Iwaizumi, Yoshitaka Matsushima, Yukari Totsuka, Hitoshi Nakagama, Masako Kasami, Hideto Ochiai, Keigo Matsumoto, Shioto Suzuki, Fumihiko Tanioka, Haruhiko Sugimura. DNA adductome analyses at multiple sites of human gastric mucosa, resected for gastric cancer. [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 4619. doi:10.1158/1538-7445.AM2015-4619


Journal of Surgical Research | 1997

Pancreatic Damage Resulting from Temporary Portal Triad Interruption during Partial Hepatectomy: Protective Effect of a Prostaglandin I2Analogue

Hideto Ochiai; Satoshi Nakamura; Shohachi Suzuki; Shozo Baba; Satoshi Baba


Nihon Gekakei Rengo Gakkaishi (journal of Japanese College of Surgeons) | 2016

Laparoscopic Operation for Right Paraduodenal Hernia with Intestinal Malrotation in Adult: Report of a Case

Sanshiro Kawata; Keisuke Inaba; Atsuko Fukazawa; Kazuhiko Fukumoto; Osamu Jindou; Akihiro Uno; Keigo Matshumoto; Hideto Ochiai; Shohachi Suzuki; Hiroshi Kitamura

Collaboration


Dive into the Hideto Ochiai's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge